News
Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression ... progressed during or after an aromatase inhibitor alone or with a CDK4/6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback